Your session is about to expire
← Back to Search
Live Donor Champion Program for Kidney Disease (LDC Trial)
N/A
Waitlist Available
Led By Dorry L Segev, MD PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
If there is an individual willing to donate, but the candidate is unwilling to consider this option or this particular individual, the candidate is eligible for the trial and may still benefit from identification of new donors or increased comfort accepting donation from others.
Kidney transplant candidates aged≥18 added to the waitlist in the last year with no potential live donors are eligible.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 6 months of enrollment
Awards & highlights
LDC Trial Summary
This trial is being conducted to help patients with end stage renal disease by teaching them about kidney transplantation and live kidney donation. The program also encourages patients to bring family and friends to participate in the program and act as advocates on their behalf.
Who is the study for?
This trial is for adults over 18 on the kidney transplant waitlist within the last year without live donors. It's open to English speakers at University or University of Alabama, and English or Spanish speakers at Northwestern University. Friends or family willing to advocate for patients can join as 'Live Donor Champions'. Those with potential donors under evaluation or previous transplants are excluded.Check my eligibility
What is being tested?
The Live Donor Champion Program educates patients about kidney failure, transplantation, and finding live donors. The study tests how well this program works in a clinical setting by helping participants increase their knowledge and identify potential donors through support from friends and family acting as advocates.See study design
What are the potential side effects?
Since this is an educational program rather than a medical treatment, there are no direct physical side effects associated with participating in the trial itself.
LDC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am open to considering new organ donors or becoming more comfortable with the idea of receiving a donation.
Select...
I am over 18, need a kidney transplant, and have no live donors.
Select...
I am 18 years old or older.
Select...
I speak English.
Select...
I speak English or Spanish.
Select...
I speak English.
LDC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 6 months of enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 6 months of enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability - Implementation Outcome
Adoption - Implementation Outcome
Appropriateness - Implementation Outcome
+5 moreSecondary outcome measures
Comfort initiating conversations
Knowledge of live donation and kidney transplantation
Live Donor Inquiries
+1 moreLDC Trial Design
1Treatment groups
Experimental Treatment
Group I: Live Donor ChampionExperimental Treatment1 Intervention
The Live Donor Champion program is the sole educational intervention for this trial. LDC consists of 6 monthly sessions of approx. 1 hour each. Each LDC session is led by a transplant physician or clinical coordinator. LDC sessions incorporate formal didactics, active-participant learning, personal stories, moderated group discussions, role-playing, and other skill-building exercises. LDC sessions are as follows: 1) education about ESRD, KT, and LDKT 2) communication skills building 3) Exploring social networks 4) sharing successful donor and recipient stories 5) encouraging candidate self-efficacy 6) Program Recap.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,257 Previous Clinical Trials
14,820,020 Total Patients Enrolled
Dorry L Segev, MD PhDPrincipal InvestigatorJohns Hopkins University
Elizabeth King, MD PhDPrincipal InvestigatorJohns Hopkins University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old and do not speak English.I am over 18, need a kidney transplant, and have no live donors.I am open to considering new organ donors or becoming more comfortable with the idea of receiving a donation.You are a friend, family member, or community member willing to speak up for the patient on the waiting list.I am 18 years old or older.I speak English.I speak English or Spanish.I speak English.I am 18 or older, speak English, and am involved with the LDC program.
Research Study Groups:
This trial has the following groups:- Group 1: Live Donor Champion
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who meets the eligibility requirements for participation in this clinical research?
"This clinical trial is recruiting 210 participants who must have a history of chronic kidney failure, and fit within the age range between 18 years old to 100."
Answered by AI
Are geriatric patients included in this research program?
"This medical study is open to patients between 18 and 100 years old. Meanwhile, there are 13 studies for minors under the age of 18 and 174 trials that cater to individuals over 65."
Answered by AI
What results is this study aiming to uncover?
"This two-year trial will evaluate the feasibility of implementation outcome as its primary goal. Participants' comfort initiating conversations, knowledge of live donation and kidney transplantation, and if they have undergone a Live donor kidney transplantation within one year since enrollment are secondary measurements that shall be collected through surveys and medical records respectively."
Answered by AI
Is access to this research being made available for potential participants?
"Clinicaltrials.gov reflects that this investigation, which was first announced on May 30th 2018 and recently edited on February 2nd 2022 is not currently recruiting patients. However there are 180 other trials actively looking for volunteers to join their studies."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger